• Disrupting Power Since 2015
  • Donate
  • Login
Wednesday, May 14, 2025
  • Login
  • Register
Canary
MEDIA THAT DISRUPTS
  • News
    • UK
    • Global
    • Analysis
    • Trending
  • Editorial
  • Features
    • Features
    • Environment
    • Lifestyle
    • Health
    • Money
    • Science
    • Business
    • Tech
    • Travel
    • Sport & Gaming
  • Media
    • Video
    • Cartoons
  • Opinion
No Result
View All Result
MANAGE SUBSCRIPTION
SUPPORT
  • News
    • UK
    • Global
    • Analysis
    • Trending
  • Editorial
  • Features
    • Features
    • Environment
    • Lifestyle
    • Health
    • Money
    • Science
    • Business
    • Tech
    • Travel
    • Sport & Gaming
  • Media
    • Video
    • Cartoons
  • Opinion
No Result
View All Result
Canary
No Result
View All Result

Precision medicine – putting a chink in breast cancer’s armour

Kathryn Loydall by Kathryn Loydall
10 May 2016
in Health, Science
Reading Time: 3 mins read
168 4
A A
0
Home Other News & Features Health
319
SHARES
2.5k
VIEWS
Share on FacebookShare on Twitter

*CONTENT WARNING – discussion of use of animals in research*

Triple negative breast cancer is notoriously difficult to treat – it lacks the receptors that would allow it to respond to many of the drugs used for other forms of breast cancer. However, for the first time, a new drug candidate has been designed using genetic sequencing to specifically trigger tumour cells into killing themselves, leaving healthy cells untouched.

Difficult to treat

As many as 10-20% of all breast cancers can be defined as triple negative breast cancers. This type of breast cancer doesn’t have estrogen, progesterone, or HER2 receptors. And because it doesn’t have these receptors, it doesn’t respond to hormonal therapies or to treatments that target HER2 receptors (e.g. Herceptin), which are often used to treat other types of breast cancer.

In other words, it won’t respond to therapies that “starve” the cancer cells of their energy. It also tends to be more aggressive. Therefore, people suffering from this form of the disease are usually treated with more toxic forms of chemotherapy, combined with surgery and radiation.

Because as many as 10-20% of all breast cancers are triple negative, there is intense research in the area.

New drug candidate

A paper being published in the Proceedings of the National Academy of Science by a team from The Scripps Research Institute (TSRI) this week, however, describes a new drug candidate that has been shown to decrease the growth of tumour cells in animal models.

The study demonstrates that a compound known as Targaprimir-96 triggers breast cancer cells to kill themselves. It does this by specifically targeting a folded section of micro ribonucleic acid (microRNA) that is involved in “igniting” the cancer.

The breast cancer cells – and importantly, not healthy cells – then kill themselves via a process called programmed cell death.

MicroRNAs are short molecules that work within all animal and plant cells, typically functioning as a “dimmer switch” for one or more genes. Various microRNAs have been associated with diseases. The target of the study, microRNA-96, promotes cancer by discouraging programmed cell death, which can rid the body of cells that grow out of control.

Precision medicine

TSRI Professor Matthew Disney, leader of the study, says:

This is the first example of taking a genetic sequence and designing a drug candidate that works effectively in an animal model against triple negative breast cancer

Disney credits the successful study to advances in precision medicine, an emerging approach to treat and prevent disease in a more customised way:

The study represents a clear breakthrough in precision medicine, as this molecule only kills the cancer cells that express the cancer-causing gene—not healthy cells. These studies may transform the way the lead drugs are identified—by using the genetic makeup of a disease.

In the study, the drug candidate was tested in animal models over a period of 21 days. The results showed decreased production of microRNA-96 and increased programmed cell death, which significantly reduced tumour growth. Healthy cells were unaffected.

In contrast, Disney noted, a typical cancer therapeutic targets and kills cells indiscriminately, often leading to side effects that can make these drugs difficult for patients to tolerate.

Precision medicine, in the past, has typically involved time-consuming and expensive high-throughput screens to test millions of potential drug candidates to identify those few that affect the target of interest.

The team from TSRI, however, used an approach that eliminates these screens. The new study uses the lab’s computational approach called Inforna, which focuses on developing designer compounds that bind to RNA folds, particularly microRNAs.

First author of the study and member of the Disney lab, Research Associate Sai Pradeep Velagapudi added:

In the future we hope to apply this strategy to target other disease-causing RNAs, which range from incurable cancers to important viral pathogens such as Zika and Ebola.

While clearly preliminary, the study shows how precision medicine has come along in leaps and bounds and offers a glimmer of hope for those suffering from this difficult to treat cancer.

 

Full article information: Sai Pradeep Velagapudi et al., “Design of a Small Molecule Against an Oncogenic Non-coding RNA” Proceedings of the National Academy of Sciences, published online ahead of print on May 9, 2016.
Featured image via Flickr / F. // Chicca // K. Silva

Share128Tweet80
Previous Post

Boris Johnson tries to convince people to Brexit. By singing (VIDEO)

Next Post

Labour MP forced to backtrack after having ‘knifed’ Corbyn (TWEETS)

Next Post
Blairites may hate Corbyn, but it’s who loves him that matters

Labour MP forced to backtrack after having 'knifed' Corbyn (TWEETS)

These new billboards are going up across Britain, and David Cameron will not be amused (IMAGES)

These new billboards are going up across Britain, and David Cameron will not be amused (IMAGES)

The greatest tax scandal in history exposes David Cameron’s own millionaire father

EXCLUSIVE: Here are the top Tories revealed in the latest Panama Papers scandal

Leaked primary school tests are blamed on act of resistance to government policy

Leaked primary school tests are blamed on act of resistance to government policy

These amazing letters from teachers to children before their tests are going viral (IMAGES)

These amazing letters from teachers to children before their tests are going viral (IMAGES)

hygiene poverty
Analysis

1.1 million kids are in ‘hygiene poverty’ – yet no one in government wants to act

by Steve Topple
14 May 2025
Another DWP pensions scandal hitting women is "the biggest of modern times"
Analysis

Another DWP pensions scandal hitting women is “the biggest of modern times”

by Steve Topple
14 May 2025
An open letter from Jewish people calls out the Board of Deputies for stifling criticism of Israel
News

An open letter from Jewish people calls out the Board of Deputies for stifling criticism of Israel

by The Canary
14 May 2025
Image via Zkiah Smith of Greenwich council flats
Analysis

Greenwich council at the centre of a growing fire safety scandal in block of new flats

by HG
14 May 2025
dyfed pension fund actually has over £200m invested in Israel
News

Welsh pension fund has more than 180 times the investments in Israel it claims, so campaigners are taking action

by The Canary
14 May 2025
  • Contact
  • About & FAQ
  • Get our Daily News Email
  • Privacy Policy
  • Cookie Policy

The Canary
PO Box 71199
LONDON
SE20 9EX

Canary Media Ltd – registered in England. Company registration number 09788095.

For guest posting, contact [email protected]

For other enquiries, contact: [email protected]

The Canary is owned and run by independent journalists and volunteers, NOT offshore billionaires.

You can write for us, or support us by making a regular or one-off donation.

© Canary Media Ltd 2024, all rights reserved | Website by Monster | Hosted by Krystal | Privacy Settings

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • News
    • UK
    • Global
    • Analysis
    • Trending
  • Editorial
  • Features
    • Features
    • Environment
    • Lifestyle
    • Health
    • Money
    • Science
    • Business
    • Tech
    • Travel
    • Sport & Gaming
  • Media
    • Video
    • Cartoons
  • Opinion

© 2023 Canary - Worker's co-op.

Before you go, have you seen...?

hygiene poverty
Analysis
Steve Topple

1.1 million kids are in ‘hygiene poverty’ – yet no one in government wants to act

Another DWP pensions scandal hitting women is "the biggest of modern times"
Analysis
Steve Topple

Another DWP pensions scandal hitting women is “the biggest of modern times”

An open letter from Jewish people calls out the Board of Deputies for stifling criticism of Israel
News
The Canary

An open letter from Jewish people calls out the Board of Deputies for stifling criticism of Israel

Image via Zkiah Smith of Greenwich council flats
Analysis
HG

Greenwich council at the centre of a growing fire safety scandal in block of new flats

ADVERTISEMENT
Business
Nathan Spears

When digital isn’t enough: why paper still matters in modern business

Tech
Nathan Spears

How Digital Addictions Are Formed in the Shadow of Large Platforms

Lifestyle
Nathan Spears

Recovery in the Sun: How the Canary Islands are Becoming a Wellness Tourism Hub